Resource Center

Always with a focus on innovation, find resources that share our scientific experts passion and knowledge. Find case studies, info sheets, posters and more.
Quotient Sciences Logo
Clinical Pharmacology, First-in-Human, Proof-of-Concept, Patient Trials

First-in-Human Trials to Proof of Concept Info Sheet

14 October 2025 Download

171 - 180 of 223 results

Case Studies, Formulation Development, Dr. Andy Lewis
Case Study: DCS Classification of NCE
Download Now
Whitepapers, Oncology, Clinical Pharmacology, Translational Pharmaceutics
Accelerating the Development of Oncology Medicines
Download Now
Whitepapers, Modified Release, Clinical Pharmacology
Accelerating the Development of Enabled Formulations for Poorly Soluble Drugs using Translational Pharmaceutics
Download Now
Scientific Posters, Formulation Development
Applications of Lipid-based Formulations and the Benefits of Integrating Manufacturing and Clinical Testing in Formulation Selection
Download Now
Scientific Posters, Bioanalysis
Analysis of Ranitidine Reference Materials Using a Six N-Nitrosamine LC-MS/MS Assay
Download Now
Scientific Posters, Bioanalysis
EBF 2021: Novel Copper Protein Speciation Method for Calculating Serum Non Ceruloplasmin Copper: A Comparative Analysis
Download Now
Scientific Posters, Bioanalysis
EBF 2021: Analysis of Ranitidine Reference Materials Using a Six N-Nitrosamine LC-MS/MS Assay
Download Now
Scientific Posters, Solubility Enhancement, Modified Release, Modelling & Simulation
AAPS 2021: Development and Application of a PBPK Model Using Theoretical Particle Size Distribution to Describe in vivo D issolution to Predict the Impact of Formulation Changes on Oral Bioavailability of GB001
Download Now
Scientific Posters, Clinical Pharmacology, First-in-Human
ASCPT 2021 Poster: A First in Human (FIH) Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses, and Alternative Formulations of R941552 (R552): A selective Receptor Interacting Protein 1 (RIP1) Kinase Inhibitor
Download Now
Scientific Posters, Clinical Pharmacology
HBI-3000: A Novel Drug for Conversion of Atrial Fibrillation - Phase 1 Study Results
Download Now